Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy

QR Code

Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy

Tomoaki Higashiyama, Masahito Ohji Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan Purpose: This study was performed to observe changes prospectively in exophthalmos and orbital fat in patients with inactive thyroid-associated ophthalmopathy (TAO) treated with bimatop...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Higashiyama T, Ohji M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	Bimatoprost Thyroid-associated ophthalmopathy Exophthalmos Orbital fat Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/938e3ba68e7049269ca7278e9742134b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Hertel exophthalmometer versus computed tomography scan in proptosis estimation in thyroid-associated orbitopathy
par: Park NR, et autres
Publié: (2019)

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY
par: V. G. Likhvantseva, et autres
Publié: (2017)

Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy
par: Higashiyama T, et autres
Publié: (2016)

Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
par: Suzuki N, et autres
Publié: (2018)

Single nucleotide polymorphism 1623 A/G (rs180195) in the promoter of the Thyroglobulin gene is associated with autoimmune thyroid disease but not with thyroid ophthalmopathy
par: Lahooti H, et autres
Publié: (2017)

Assessment of tear-evaporation rate in thyroid-gland patients
par: Abusharaha A, et autres
Publié: (2019)

Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association
par: Chatzistefanou KI, et autres
Publié: (2017)

Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
par: Lee D, et autres
Publié: (2017)

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% – an observational switch study
par: Deshpande SS, et autres
Publié: (2017)

Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review
par: Shanmuganathan T, et autres
Publié: (2015)

Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
par: Sayed KM, et autres
Publié: (2019)

Prevalence of increased intraocular pressure in patients with Graves’ ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran
par: Eslami F, et autres
Publié: (2019)

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
par: Stevens A, et autres
Publié: (2016)

Clinical factors affecting intraocular pressure change after orbital decompression surgery in thyroid-associated ophthalmopathy
par: Jeong JH, et autres
Publié: (2016)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
par: Shen J, et autres
Publié: (2017)

Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence
par: Qian Ge, et autres
Publié: (2021)

Evaluation of the association between subconjunctival orbital fat prolapse and thyroid-associated orbitopathy
par: Han SB
Publié: (2017)

Altered spontaneous brain activity patterns in patients with hyperthyroidism exophthalmos using amplitude of low-frequency fluctuation: a resting-state fMRI study
par: Ling Ling, et autres
Publié: (2021)

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
par: Shen J, et autres
Publié: (2016)

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
par: Pillunat LE, et autres
Publié: (2016)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
par: McCorquodale T, et autres
Publié: (2012)

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
par: Pfennigsdorf S, et autres
Publié: (2016)

Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
par: Kimihito Maeda, et autres
Publié: (2008)

Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?
par: Hooshang Lahooti, et autres
Publié: (2010)

Bimatoprost in the treatment of eyelash hypotrichosis
par: Simon K Law
Publié: (2010)

Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves’ ophthalmopathy and Hashimoto’s thyroiditis
par: Lahooti H, et autres
Publié: (2015)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
par: Tamçelik N, et autres
Publié: (2017)

Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction
par: Wall JR, et autres
Publié: (2014)

Intraocular pressure in patients with human immunodeficiency virus, correlation with TCD4, viral load and demographic characteristics: a case–control study
par: Cravo LMS, et autres
Publié: (2019)

IgG4-related disease in endocrine practice
par: Agata Rzepecka, et autres
Publié: (2018)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
par: Abayomi B Ogundele, et autres
Publié: (2010)

Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
par: Scott D Smid
Publié: (2009)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
par: Chang-Lin J-E, et autres
Publié: (2011)

Periorbital muscle atrophy associated with topical bimatoprost therapy
par: Wang PX, et autres
Publié: (2014)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
par: Selter JH, et autres
Publié: (2014)

Adiponectin concentration in the orbital fat of patients with Graves' ophthalmopathy
par: Soiberman U, et autres
Publié: (2013)

Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
par: Shafiee A, et autres
Publié: (2013)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
par: Inoue K, et autres
Publié: (2014)

Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
par: Allam IY, et autres
Publié: (2021)

Orbital Compartment Syndrome: An Update With Review Of The Literature
par: McCallum E, et autres
Publié: (2019)